R&D Published on May 11, 2020 Teams from the Faculty of Medicine and Research Centre of the CHU de Québec – Université Laval and the University of São Paulo tested the effect of rutin, a polyphenol found in many plants, including apples, on skin damage caused by exposure to UVB rays. Read more on Le Soleil
Pharma Published on May 6, 2020 Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial. Read more on Business Wire
Investment Published on May 6, 2020 Collaborative project of more than $1.2 million using artificial intelligence to optimize the production of vaccines, announced by CQDM and Medicago R&D. Read more on News Wire
R&D Published on May 6, 2020 Researchers from around the world are working to find a treatment or vaccine to stop the pandemic. Here are three Quebec initiatives that help us understand the complexity of the long struggle underway. Read more on L'actualité
Investment Published on May 6, 2020 The Montreal Heart Institute (MHI) Research Centre’s clinical study on COVID-19 was supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, one of the largest qualified medical research centres in the world. The NHLBI calls this study one of the largest in the world and is providing funding to help accelerate patient recruitment. Read more on 98,5 FM Radio
Medtech Published on May 4, 2020 A Rimouski company starts installing cameras that detect fever. Read more on Radio-Canada
Business environment Published on May 4, 2020 The Prime Minister, Justin Trudeau, joined other global leaders to launch the Coronavirus Global Response. This online pledging event aims to initially raise more than $8 billion (USD) to help researchers and innovators develop solutions to test, treat, and protect people, and to prevent the further spread of COVID-19. Read more on News Wire
Business environment Published on May 4, 2020 To help essential companies hire the right candidates more quickly, the young Montreal-based company Valital is making its recruitment platform, managed by artificial intelligence, available free of charge. Read more on Journal de Montréal
Pharma Published on April 30, 2020 Teva Canada announces the launch of AJOVY™ for the preventive treatment of migraine in adults who have at least four migraine days per month. Read more on News Wire